Efficacy of Pranlukast in subjects with Japanese Cedar pollinosis in the OHIO Chamber

Phase 4

• Conditions: Japanese cedar pollinosis

• Registration Number: JPRN-UMIN000001282
• Lead Sponsor: TOPIC Study (Trial of OHIO Chamber-Pranlukast Inhibitory Effect for Cedar Exposure-)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-08-04
• Study Completion: 2008-09-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects with a polyp or deformity of the nose. 2) Subjects who used steroid drugs for injection within 6 months before the start of this study. 3) Subjects with systemic diseases ( asthma or tuberculosis ). 4) Subjects with build-up phase of immunotherapy to Japanese cedar pollen. 5) Subjects with pregnancy, lactation or potential pregnancy. 6) Subjects who are inappropriate to this study by the judgment of doctor.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
nose and eye symptoms

Secondary Outcome Measures

Name	Time	Method
the number of sneezing, the amount of nasal secretion, the manifestation time of nasal symptoms, nasal airway resistance, respiratory function and performance test( D-CAT )